Lifetime Insurance Caps

The Caring for Carcinoid Foundation encourages all carcinoid and related neuroendocrine tumor patients to join NORD (National Organization of Rare Disorders) in its fight to end lifetime insurance caps as soon as possible. Many patients must seek out costly therapeutic alternatives in order to receive the best care available. Furthermore, this issue is particularly relevant to patients with carcinoid and related neuroendocrine tumors as they may require chronic care and high-cost drug therapies. Therefore, CFCF supports NORD in rejecting lifetime insurance caps in insurance markets.

What is a lifetime insurance cap?

A lifetime insurance cap is a method used by health insurance companies to limit the total amount that will be paid out. In that way they are similar to deductibles and co-payments, except instead of asking for money out-of-pocket from insurers, they are limiting, or setting a cap, on the amount that people with health insurance will receive for their health care. As the name implies, this cap on payouts is for the entire life of the individual who is insured, the only way to get a reset is to find a new insurance plan. Finding a new insurance plan can become difficult to impossible in many instances where that insurance cap has been used up.

Why does this matter for me?

This is an issue that should matter to everyone for a number of reasons. First, rising health care costs means that fixed caps become increasingly inappropriate. From 2000 to 2008, national health care expenditures increased by 13.6% (HUS 2008), and they are projected to continue rising at high rates. A million dollar payout at the beginning of that period is therefore worth less (gets you less care) than the same amount in 2008, and increasingly less in the future.

This is a particularly critical issue for patients with rare and/or chronic diseases like carcinoid and NETs, which anybody can fall victim to. This matters because diseases that are rare and/or chronic tend to be more expensive. Rarity drives up costs because effective treatment methods such as pharmaceuticals and technologies have not been developed to the same degree as more common diseases, and what treatments there are tend to cost more. There are a number of contributing factors to this, including the necessary incentive structure for enticing drug companies to develop treatments.

Chronic conditions, especially those without a cure, cost more than acute conditions for more obvious reasons. The continuous need for care builds up and becomes very expensive over time. A 2 million dollar cap could quickly disappear in the span of a few surgeries. With a condition such as carcinoid that is both rare and chronic, it is easy for patients to burn through the lifetime cap, leaving them with no insurance to cover their necessary continuing care.

Carcinoid is a disease that is both rare and chronic, and therefore people with this condition should be particularly concerned about lifetime caps and how to reform them.

Here is some information on carcinoid and NETs:

While the age adjusted incidence (number of new cases over a given time) for neuroendocrine tumors has increased from 1973 to 2004, the estimated 29-year limited duration prevalence (number of people alive with a disease diagnosed within the last 29 years) as of January 1, 2004 was 103,312 in the United States, making carcinoid and NETs a rare condition. Data is from research done by Dr. James Yao in “One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States”.

As a result, the comparatively fewer available therapies and surgeries tend to be more expensive, for reasons previously mentioned. This increase does not include non-medical costs. An example of this may be a person who does not have anyone in close proximity that is capable of giving the best, or even decent level of care because of the rarity of their disease. As a result, they may be forced to travel great distances just to receive care, and be burdened with all the associated costs of doing so.

Finally, carcinoid, like many cancers, is chronic and deadly. There is currently no cure for carcinoid, meaning that there is no specific time period when treatment will no longer be necessary. This means that even if costs of treatment weren’t already high, the considerable time frame for treatment alone could easily leave someone with a low lifetime insurance cap with no resources after a few years.

What can I do?

Many groups are currently fighting to reform the current lifetime caps on insurance plans. The National Organization for Rare Diseases (NORD) is advocating the elimination of lifetime caps by supporting a letter being circulated by Rep. Patrick Kennedy. Your support would be tremendously helpful. I have included contact information for Representatives and Senators, in addition to a template provided by NORD, we at CFCF encourage you to call or e-mail them soon.

Call the switchboard at (202) 224-3121 and ask to be transferred to your local representative.

Find House e-mail addresses here: http://www.house.gov/

Find Senator e-mail addresses here: http://www.senate.gov/

Here is the template, feel free to modify and personalize it in any way that suits you.

Good morning/afternoon. My name is _____________________ and I am a constituent living in (city, state). I have a rare disease.

I am calling to bring to your attention a letter that Rep. Patrick Kennedy is circulating in Congress. This letter calls for the immediate abolition of lifetime insurance caps in the House health care reform bill, HR 3200.

As this bill is currently written, patients may have to wait up to nine years after reform is enacted to see those lifetime caps eliminated. People like me who have rare diseases face possible financial ruin if lifetime insurance caps are not immediately abolished. This issue is very important to me.

Will Representative (insert name of your Representative) sign on to Patrick Kennedy's letter?